Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$919K Sell
2,758
-91
-3% -$30.2K ﹤0.01% 1468
2026
Q1
$828K Sell
2,849
-209
-7% -$66.9K ﹤0.01% 1406
2025
Q4
$921K Buy
3,058
+1,990
+186% +$578K ﹤0.01% 1266
2025
Q3
$295K Sell
1,068
-49
-4% -$15.6K ﹤0.01% 1763
2025
Q2
$377K Buy
1,117
+113
+11% +$36.9K ﹤0.01% 1493
2025
Q1
$349K Buy
1,004
+108
+12% +$39K ﹤0.01% 1330
2024
Q4
$309K Buy
+896
New +$315K ﹤0.01% 1324

Other funds holding CPAY

&Partners's CPAY Position: Q2 2026 in Review

&Partners reduced its Corpay (CPAY) stake by 3.2% in Q2 2026, selling an estimated $30.2K and leaving 2,758 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

&Partners first reported a position in CPAY in Q4 2024 and has held it in 7 quarters since. The position peaked at $921K in Q4 2025. 727 funds tracked by Wall St. Rank hold CPAY as of Q2 2026.

  • &Partners held 2,758 shares of Corpay worth $919K as of Q2 2026.
  • &Partners sold 91 Corpay shares in Q2 2026, an estimated $30.2K.
  • Corpay made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1468 holding.
  • &Partners first reported a position in Corpay in Q4 2024 and has held it in 7 quarters since.
  • &Partners's Corpay position peaked at $921K in Q4 2025.
  • 727 funds tracked by Wall St. Rank held Corpay as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.